IT1397617B1 - Nuovi derivati della rifamicina - Google Patents

Nuovi derivati della rifamicina

Info

Publication number
IT1397617B1
IT1397617B1 ITMI2009A000653A ITMI20090653A IT1397617B1 IT 1397617 B1 IT1397617 B1 IT 1397617B1 IT MI2009A000653 A ITMI2009A000653 A IT MI2009A000653A IT MI20090653 A ITMI20090653 A IT MI20090653A IT 1397617 B1 IT1397617 B1 IT 1397617B1
Authority
IT
Italy
Prior art keywords
derivatives
new french
french
new
french derivatives
Prior art date
Application number
ITMI2009A000653A
Other languages
English (en)
Inventor
Goffredo Rosini
Paolo Righi
Giuseppe Claudio Viscomi
Mahena Folegatti
Manuela Campana
Vincenzo Cannata
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Priority to ITMI2009A000653A priority Critical patent/IT1397617B1/it
Priority to US12/473,260 priority patent/US8318763B2/en
Priority to ES10714069.1T priority patent/ES2535327T3/es
Priority to JP2012505257A priority patent/JP5661100B2/ja
Priority to DK10714069.1T priority patent/DK2421869T3/da
Priority to MX2011011026A priority patent/MX338334B/es
Priority to KR1020117013848A priority patent/KR101555860B1/ko
Priority to AU2010240638A priority patent/AU2010240638B2/en
Priority to PCT/IB2010/051183 priority patent/WO2010122436A1/en
Priority to CN2010800174395A priority patent/CN102405223A/zh
Priority to SG2011041225A priority patent/SG171989A1/en
Priority to UAA201106234A priority patent/UA105775C2/uk
Priority to BRPI1005979A priority patent/BRPI1005979A8/pt
Priority to PL10714069T priority patent/PL2421869T3/pl
Priority to EP10714069.1A priority patent/EP2421869B1/en
Priority to MA33963A priority patent/MA33320B1/fr
Priority to CA2743801A priority patent/CA2743801C/en
Priority to NZ595884A priority patent/NZ595884A/xx
Priority to EA201190216A priority patent/EA020201B1/ru
Priority to PT107140691T priority patent/PT2421869E/pt
Priority to TW099111234A priority patent/TWI422372B/zh
Priority to ARP100101301A priority patent/AR076340A1/es
Publication of ITMI20090653A1 publication Critical patent/ITMI20090653A1/it
Priority to IL212942A priority patent/IL212942A/en
Priority to TN2011000265A priority patent/TN2011000265A1/fr
Priority to HR20110437A priority patent/HRP20110437A2/hr
Priority to CO11078443A priority patent/CO6362013A2/es
Priority to CL2011002597A priority patent/CL2011002597A1/es
Priority to HK12103912.5A priority patent/HK1163663A1/xx
Priority to US13/684,803 priority patent/US8765778B2/en
Publication of IT1397617B1 publication Critical patent/IT1397617B1/it
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
ITMI2009A000653A 2009-04-20 2009-04-20 Nuovi derivati della rifamicina IT1397617B1 (it)

Priority Applications (29)

Application Number Priority Date Filing Date Title
ITMI2009A000653A IT1397617B1 (it) 2009-04-20 2009-04-20 Nuovi derivati della rifamicina
US12/473,260 US8318763B2 (en) 2009-04-20 2009-05-27 Rifamycin derivatives
NZ595884A NZ595884A (en) 2009-04-20 2010-03-18 Rifamycin derivatives derived from microorganisms and their use as antibacterial agents
JP2012505257A JP5661100B2 (ja) 2009-04-20 2010-03-18 リファマイシン誘導体
MX2011011026A MX338334B (es) 2009-04-20 2010-03-18 Derivados de rifamicina.
KR1020117013848A KR101555860B1 (ko) 2009-04-20 2010-03-18 리파마이신 유도체
AU2010240638A AU2010240638B2 (en) 2009-04-20 2010-03-18 Rifamycin derivatives
PCT/IB2010/051183 WO2010122436A1 (en) 2009-04-20 2010-03-18 Rifamycin derivatives
CN2010800174395A CN102405223A (zh) 2009-04-20 2010-03-18 利福霉素衍生物
SG2011041225A SG171989A1 (en) 2009-04-20 2010-03-18 Rifamycin derivatives
UAA201106234A UA105775C2 (uk) 2009-04-20 2010-03-18 Похідні рифаміцину
BRPI1005979A BRPI1005979A8 (pt) 2009-04-20 2010-03-18 Derivados de rifamicina
PL10714069T PL2421869T3 (pl) 2009-04-20 2010-03-18 Pochodna rifamycyny
EP10714069.1A EP2421869B1 (en) 2009-04-20 2010-03-18 Rifamycin derivative
ES10714069.1T ES2535327T3 (es) 2009-04-20 2010-03-18 Derivados de rifamicina
MA33963A MA33320B1 (fr) 2009-04-20 2010-03-18 Derives de rifamycine
DK10714069.1T DK2421869T3 (da) 2009-04-20 2010-03-18 Rifamycinderivat
EA201190216A EA020201B1 (ru) 2009-04-20 2010-03-18 Производные рифамицина
PT107140691T PT2421869E (pt) 2009-04-20 2010-03-18 Derivado de rifamicina
CA2743801A CA2743801C (en) 2009-04-20 2010-03-18 Rifamycin derivatives
TW099111234A TWI422372B (zh) 2009-04-20 2010-04-12 利福黴素（ｒｉｆａｍｙｃｉｎ）衍生物
ARP100101301A AR076340A1 (es) 2009-04-20 2010-04-20 Derivados de rifamicina
IL212942A IL212942A (en) 2009-04-20 2011-05-17 History of Rifamycin, Methods of Preparation, Pharmaceutical Preparations Containing Them and Their Uses
TN2011000265A TN2011000265A1 (en) 2009-04-20 2011-05-24 Rifamycin derivatives
HR20110437A HRP20110437A2 (hr) 2009-04-20 2011-06-10 Derivati rifamicina
CO11078443A CO6362013A2 (es) 2009-04-20 2011-06-22 Derivados de rifamicina
CL2011002597A CL2011002597A1 (es) 2009-04-20 2011-10-18 Compuestos derivados de rifamicina; procedimiento de preparacion; composicion farmaceutica; su uso para tratar, prevenir o aliviar sobrecrecimiento bacteriano en trastornos intestinales tales como sindrome de colon irritable, diarrea del viajante, enfermedad de crohn, encefalopatia hepatica y enteritis.
HK12103912.5A HK1163663A1 (en) 2009-04-20 2012-04-19 Rifamycin derivatives
US13/684,803 US8765778B2 (en) 2009-04-20 2012-11-26 Rifamycin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A000653A IT1397617B1 (it) 2009-04-20 2009-04-20 Nuovi derivati della rifamicina

Publications (2)

Publication Number Publication Date
ITMI20090653A1 ITMI20090653A1 (it) 2010-10-21
IT1397617B1 true IT1397617B1 (it) 2013-01-18

Family

ID=41228810

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A000653A IT1397617B1 (it) 2009-04-20 2009-04-20 Nuovi derivati della rifamicina

Country Status (28)

Country Link
US (2) US8318763B2 (it)
EP (1) EP2421869B1 (it)
JP (1) JP5661100B2 (it)
KR (1) KR101555860B1 (it)
CN (1) CN102405223A (it)
AR (1) AR076340A1 (it)
AU (1) AU2010240638B2 (it)
BR (1) BRPI1005979A8 (it)
CA (1) CA2743801C (it)
CL (1) CL2011002597A1 (it)
CO (1) CO6362013A2 (it)
DK (1) DK2421869T3 (it)
EA (1) EA020201B1 (it)
ES (1) ES2535327T3 (it)
HK (1) HK1163663A1 (it)
HR (1) HRP20110437A2 (it)
IL (1) IL212942A (it)
IT (1) IT1397617B1 (it)
MA (1) MA33320B1 (it)
MX (1) MX338334B (it)
NZ (1) NZ595884A (it)
PL (1) PL2421869T3 (it)
PT (1) PT2421869E (it)
SG (1) SG171989A1 (it)
TN (1) TN2011000265A1 (it)
TW (1) TWI422372B (it)
UA (1) UA105775C2 (it)
WO (1) WO2010122436A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2522895T3 (es) 2005-03-03 2014-11-19 Alfa Wassermann S.P.A. Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
AU2013315458A1 (en) * 2012-09-12 2015-03-05 Salix Pharmaceuticals, Inc. Methods of administering rifaximin without producing antibiotic resistance
CN103709177B (zh) * 2013-12-20 2016-02-24 武汉工程大学 利福霉素类沃尼妙林杂合抗生素及其制备方法
KR102362719B1 (ko) * 2014-05-12 2022-02-14 알파시그마 에스.피.에이. 리팍시민의 신규한 용매화 결정 형태, 생산물, 조성물 및 이의 용도
CN110770244A (zh) * 2017-06-26 2020-02-07 倍尔福股份公司 吡啶并咪唑利福霉素衍生物的抗菌剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH547854A (de) * 1969-05-30 1974-04-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von antibiotika.
SU465795A3 (ru) * 1972-05-05 1975-03-30 Группо Лепетит (Фирма) Способ получени рифамицина в.
US3847903A (en) * 1973-03-01 1974-11-12 Archifar Ind Chim Trentino Method for extracting and isolating rifamycin o from fermentation broths of rifamycins
CH571064A5 (en) * 1973-03-01 1975-12-31 Archifar Ind Chim Trentino Recovery of rieamycin from broths - by oxidn to an insol form
US4267274A (en) * 1973-04-26 1981-05-12 Gruppo Lepetit S.P.A. Streptomyces mediterranei mutant capable of production of rifamycin B
GB1470426A (en) * 1974-08-30 1977-04-14 Lepetit Spa Rifamycins
IT1154655B (it) * 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
IT1199374B (it) * 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin

Also Published As

Publication number Publication date
AU2010240638A1 (en) 2010-10-28
HK1163663A1 (en) 2012-09-14
IL212942A (en) 2015-06-30
MX338334B (es) 2016-04-11
AU2010240638B2 (en) 2014-06-05
ITMI20090653A1 (it) 2010-10-21
IL212942A0 (en) 2011-07-31
JP5661100B2 (ja) 2015-01-28
TW201039819A (en) 2010-11-16
TWI422372B (zh) 2014-01-11
NZ595884A (en) 2012-12-21
US8765778B2 (en) 2014-07-01
KR101555860B1 (ko) 2015-09-25
TN2011000265A1 (en) 2012-12-17
MA33320B1 (fr) 2012-06-01
BRPI1005979A8 (pt) 2017-12-26
SG171989A1 (en) 2011-07-28
DK2421869T3 (da) 2015-06-08
EA020201B1 (ru) 2014-09-30
HRP20110437A2 (hr) 2011-09-30
US20100267654A1 (en) 2010-10-21
EP2421869A1 (en) 2012-02-29
MX2011011026A (es) 2011-11-02
AR076340A1 (es) 2011-06-01
JP2012524060A (ja) 2012-10-11
UA105775C2 (uk) 2014-06-25
EA201190216A1 (ru) 2012-02-28
KR20120014110A (ko) 2012-02-16
ES2535327T3 (es) 2015-05-08
US8318763B2 (en) 2012-11-27
PT2421869E (pt) 2015-04-29
BRPI1005979A2 (pt) 2016-02-10
WO2010122436A1 (en) 2010-10-28
PL2421869T3 (pl) 2015-08-31
EP2421869B1 (en) 2015-03-11
CN102405223A (zh) 2012-04-04
CL2011002597A1 (es) 2012-03-23
CO6362013A2 (es) 2012-01-20
CA2743801C (en) 2017-03-07
CA2743801A1 (en) 2010-10-28
US20130287692A1 (en) 2013-10-31

Similar Documents

Publication Publication Date Title
SMT201600298B (it) Derivati n3-sostituiti-n1-solfonil-5- fluoropirimidinone
ECSP12011999A (es) Derivados benzamida sustituidos
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
DK2397480T3 (da) Diazepindionderivat
DK2409024T3 (da) Turbineindretning
BRPI1013844A2 (pt) derivados de piridina-isoxazol
IT1397617B1 (it) Nuovi derivati della rifamicina
SMT201400080B (it) Derivati di pirazinoossazepina
SMT201600076B (it) Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo
DK2387580T3 (da) Deoxyactagardinderivater
BR112012000657A2 (pt) novos azabicilohexanos
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
BRPI1005412A2 (pt) lâmpada
DE112010000691A5 (de) Chromatographievorrichtung
BRPI1011416A2 (pt) derivados de antraquinova novos
BR112012002810A2 (pt) derivados de n1-acil-5-fluoropirimidinona
SMT201600405B (it) Derivati di arilalchilamminocarbossammide fluorurati
SMT201500113B (it) Processp per preparare derivati di alfa-carbossammide
DK2380892T3 (da) Imidazothiazolderivat med prolinringstruktur
ATE557242T1 (de) Leuchte
SMT201500067B (it) Derivati di acilbenzene
IT1393323B1 (it) Orologio da polso
SMT201300010B (it) Derivati di piridazinoni
IT1400234B1 (it) Derivati esterei di fenilpropanoidi